-
1
-
-
20144378943
-
Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents
-
DOI 10.1021/jm040190e
-
3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents J. Med. Chem. 2005, 48, 3663-79 (Pubitemid 40776839)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.11
, pp. 3663-3679
-
-
Newman, A.H.1
Grundt, P.2
Nader, M.A.3
-
2
-
-
77949300041
-
Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders
-
Heidbreder, C. A.; Newman, A. H. Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders Ann. N. Y. Acad. Sci. 2010, 1187, 4-34
-
(2010)
Ann. N. Y. Acad. Sci.
, vol.1187
, pp. 4-34
-
-
Heidbreder, C.A.1
Newman, A.H.2
-
3
-
-
0033838517
-
3 receptor antagonist, SB-277011-A
-
Reavill, C.; Taylor, S. G.; Wood, M. D.; Ashmeade, T.; Austin, N. E.; Avenell, K. Y.; Boyfield, I.; Branch, C. L.; Cilia, J.; Coldwell, M. C.; Hadley, M. S.; Hunter, A. J.; Jeffrey, P.; Jewitt, F.; Johnson, C. N.; Jones, D. N.; Medhurst, A. D.; Middlemiss, D. N.; Nash, D. J.; Riley, G. J.; Routledge, C.; Stemp, G.; Thewlis, K. M.; Trail, B.; Vong, A. K.; Hagan, J. J. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A J. Pharmacol. Exp. Ther. 2000, 294, 1154-65 (Pubitemid 30666872)
-
(2000)
Journal of Pharmacology and Experimental Therapeutics
, vol.294
, Issue.3
, pp. 1154-1165
-
-
Reavill, C.1
Taylor, S.G.2
Wood, M.D.3
Ashmeade, T.4
Austin, N.E.5
Avenell, K.Y.6
Boyfield, I.7
Branch, C.L.8
Cilia, J.9
Coldwell, M.C.10
Hadley, M.S.11
Hunter, A.J.12
Jeffrey, P.13
Jewitt, F.14
Johnson, C.N.15
Jones, D.N.C.16
Medhurst, A.D.17
Middlemiss, D.N.18
Nash, D.J.19
Riley, G.J.20
Routledge, C.21
Stemp, G.22
Thewlis, K.M.23
Trail, B.24
Vong, A.K.K.25
Hagan, J.J.26
more..
-
4
-
-
0041919650
-
3 receptor ligands
-
3 receptor ligands J. Med. Chem. 2003, 46, 3883-99
-
(2003)
J. Med. Chem.
, vol.46
, pp. 3883-3899
-
-
Hackling, A.1
Ghosh, R.2
Perachon, S.3
Mann, A.4
Holtje, H.D.5
Wermuth, C.G.6
Schwartz, J.C.7
Sippl, W.8
Sokoloff, P.9
Stark, H.10
-
5
-
-
0242302620
-
3 Receptor Antagonist
-
3 receptor antagonist J. Med. Chem. 2003, 46, 4952-64 (Pubitemid 37355955)
-
(2003)
Journal of Medicinal Chemistry
, vol.46
, Issue.23
, pp. 4952-4964
-
-
Macdonald, G.J.1
Branch, C.L.2
Hadley, M.S.3
Johnson, C.N.4
Nash, D.J.5
Smith, A.B.6
Stemp, G.7
Thewlis, K.M.8
Vong, A.K.K.9
Austin, N.E.10
Jeffrey, P.11
Winborn, K.Y.12
Boyfield, I.13
Hagan, J.J.14
Middlemiss, D.N.15
Reavill, C.16
Riley, G.J.17
Watson, J.M.18
Wood, M.19
Parker, S.G.20
Ashby Jr., C.R.21
more..
-
6
-
-
0042921579
-
2 receptors
-
DOI 10.1021/jm0211220
-
2 receptors J. Med. Chem. 2003, 46, 3822-39 (Pubitemid 37034135)
-
(2003)
Journal of Medicinal Chemistry
, vol.46
, Issue.18
, pp. 3822-3839
-
-
Campiani, G.1
Butini, S.2
Trotta, F.3
Fattorusso, C.4
Catalanotti, B.5
Aiello, F.6
Gemma, S.7
Nacci, V.8
Novellino, E.9
Stark, J.A.10
Cagnotto, A.11
Fumagalli, E.12
Carnovali, F.13
Cervo, L.14
Mennini, T.15
-
8
-
-
27944507178
-
3 receptor ligands with improved solubility
-
DOI 10.1016/j.bmcl.2005.09.053, PII S0960894X05011674
-
3 receptor ligands with improved solubility Bioorg. Med. Chem. Lett. 2006, 16, 443-6 (Pubitemid 41680644)
-
(2006)
Bioorganic and Medicinal Chemistry Letters
, vol.16
, Issue.2
, pp. 443-446
-
-
Chen, J.1
Ding, K.2
Levant, B.3
Wang, S.4
-
9
-
-
14644386766
-
3) ligands
-
DOI 10.1016/j.bmcl.2005.01.037
-
3) ligands Bioorg. Med. Chem. Lett. 2005, 15, 1701-5 (Pubitemid 40312556)
-
(2005)
Bioorganic and Medicinal Chemistry Letters
, vol.15
, Issue.6
, pp. 1701-1705
-
-
Ji, M.1
Chen, J.2
Ding, K.3
Wu, X.4
Varady, J.5
Levant, B.6
Wang, S.7
-
10
-
-
0141992809
-
3 ligands through a hybrid pharmacophore- and structure-based database searching approach
-
DOI 10.1021/jm030085p
-
3 ligands through a hybrid pharmacophore- and structure-based database searching approach J. Med. Chem. 2003, 46, 4377-92 (Pubitemid 37238742)
-
(2003)
Journal of Medicinal Chemistry
, vol.46
, Issue.21
, pp. 4377-4392
-
-
Varady, J.1
Wu, X.2
Fang, X.3
Min, J.4
Hu, Z.5
Levant, B.6
Wang, S.7
-
11
-
-
68549110381
-
4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding
-
4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding J. Med. Chem. 2009, 52, 4923-35
-
(2009)
J. Med. Chem.
, vol.52
, pp. 4923-4935
-
-
Ehrlich, K.1
Gotz, A.2
Bollinger, S.3
Tschammer, N.4
Bettinetti, L.5
Harterich, S.6
Hubner, H.7
Lanig, H.8
Gmeiner, P.9
-
12
-
-
65249161020
-
3 receptor antagonists
-
3 receptor antagonists J. Med. Chem. 2009, 52, 2559-70
-
(2009)
J. Med. Chem.
, vol.52
, pp. 2559-2570
-
-
Newman, A.H.1
Grundt, P.2
Cyriac, G.3
Deschamps, J.R.4
Taylor, M.5
Kumar, R.6
Ho, D.7
Luedtke, R.R.8
-
13
-
-
77957909271
-
3 receptor antagonists
-
3 receptor antagonists J. Med. Chem. 2010, 53, 7129-39
-
(2010)
J. Med. Chem.
, vol.53
, pp. 7129-7139
-
-
Micheli, F.1
Arista, L.2
Bertani, B.3
Braggio, S.4
Capelli, A.M.5
Cremonesi, S.6
Di-Fabio, R.7
Gelardi, G.8
Gentile, G.9
Marchioro, C.10
Pasquarello, A.11
Provera, S.12
Tedesco, G.13
Tarsi, L.14
Terreni, S.15
Worby, A.16
Heidbreder, C.17
-
14
-
-
80051726300
-
3 Receptor Full Agonist
-
3 Receptor Full Agonist ACS Med. Chem. Lett. 2011, 2, 620-5
-
(2011)
ACS Med. Chem. Lett.
, vol.2
, pp. 620-625
-
-
Chen, J.1
Collins, G.T.2
Levant, B.3
Woods, J.4
Deschamps, J.R.5
Wang, S.6
-
15
-
-
84857650995
-
3 receptor-knockout mice
-
3 receptor-knockout mice Addict. Biol. 2012, 17, 259-73
-
(2012)
Addict. Biol.
, vol.17
, pp. 259-273
-
-
Song, R.1
Yang, R.F.2
Wu, N.3
Su, R.B.4
Li, J.5
Peng, X.Q.6
Li, X.7
Gaal, J.8
Xi, Z.X.9
Gardner, E.L.10
-
17
-
-
78449305788
-
3 selective antagonist
-
3 selective antagonist Science 2010, 330, 1091-5
-
(2010)
Science
, vol.330
, pp. 1091-1095
-
-
Chien, E.Y.1
Liu, W.2
Zhao, Q.3
Katritch, V.4
Han, G.W.5
Hanson, M.A.6
Shi, L.7
Newman, A.H.8
Javitch, J.A.9
Cherezov, V.10
Stevens, R.C.11
-
18
-
-
84864938692
-
3 receptor
-
3 receptor J. Med. Chem. 2012, 55, 6689-99
-
(2012)
J. Med. Chem.
, vol.55
, pp. 6689-6699
-
-
Newman, A.H.1
Beuming, T.2
Banala, A.K.3
Donthamsetti, P.4
Pongetti, K.5
Labounty, A.6
Levy, B.7
Cao, J.8
Michino, M.9
Luedtke, R.R.10
Javitch, J.A.11
Shi, L.12
-
20
-
-
0033595283
-
3 receptor agonist
-
DOI 10.1038/22560
-
3 receptor agonist Nature 1999, 400, 371-5 (Pubitemid 29344203)
-
(1999)
Nature
, vol.400
, Issue.6742
, pp. 371-375
-
-
Pilla, M.1
Perachon, S.2
Sautel, F.3
Garrido, F.4
Mann, A.5
Wermuth, C.G.6
Schwartz, J.-C.7
Everittt, B.J.8
Sokoloff, P.9
-
21
-
-
13444287717
-
Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl) piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor
-
DOI 10.1021/jm049465g
-
3 receptor J. Med. Chem. 2005, 48, 839-848 (Pubitemid 40209106)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.3
, pp. 839-848
-
-
Grundt, P.1
Carlson, E.E.2
Cao, J.3
Bennett, C.J.4
McElveen, E.5
Taylor, M.6
Luedtke, R.R.7
Newman, A.H.8
-
22
-
-
34548138905
-
Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl) butyl) arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: Potential substance abuse therapeutic agents
-
DOI 10.1021/jm0704200
-
3 receptor ligands: potential substance abuse therapeutic agents J. Med. Chem. 2007, 50, 4135-46 (Pubitemid 47301745)
-
(2007)
Journal of Medicinal Chemistry
, vol.50
, Issue.17
, pp. 4135-4146
-
-
Grundt, P.1
Prevatt, K.M.2
Cao, J.3
Taylor, M.4
Floresca, C.Z.5
Choi, J.-K.6
Jenkins, B.G.7
Luedtke, R.R.8
Newman, A.H.9
-
23
-
-
0031594426
-
3 dopamine receptor, in rat brain: A receptor binding and quantitative autoradiographic study
-
DOI 10.1016/S0893-133X(97)00162-0, PII S0893133X97001620
-
3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study Neuropsychopharmacology 1998, 18, 305-16 (Pubitemid 28085529)
-
(1998)
Neuropsychopharmacology
, vol.18
, Issue.4
, pp. 305-316
-
-
Bancroft, G.N.1
Morgan, K.A.2
Flietstra, R.J.3
Levant, B.4
-
25
-
-
79960349060
-
Identification of MK-5710 ((8a S)-8a-methyl-1,3-dioxo-2-[(1 S,2 R)-2-phenylcyclo- propyl]- N -(1-phenyl-1 H -pyrazol-5-yl)hexahydro-imidazo[1,5- A ]pyrazine-7(1 H)-carbox amide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2
-
Kinzel, O.; Alfieri, A.; Altamura, S.; Brunetti, M.; Bufali, S.; Colaceci, F.; Ferrigno, F.; Filocamo, G.; Fonsi, M.; Gallinari, P.; Malancona, S.; Hernando, J. I.; Monteagudo, E.; Orsale, M. V.; Palumbi, M. C.; Pucci, V.; Rowley, M.; Sasso, R.; Scarpelli, R.; Steinkuhler, C.; Jones, P. Identification of MK-5710 ((8a S)-8a-methyl-1,3-dioxo-2-[(1 S,2 R)-2-phenylcyclo- propyl]- N -(1-phenyl-1 H -pyrazol-5-yl)hexahydro-imidazo[1,5- a ]pyrazine-7(1 H)-carbox amide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2 Bioorg. Med. Chem. Lett. 2011, 21, 4429-35
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 4429-4435
-
-
Kinzel, O.1
Alfieri, A.2
Altamura, S.3
Brunetti, M.4
Bufali, S.5
Colaceci, F.6
Ferrigno, F.7
Filocamo, G.8
Fonsi, M.9
Gallinari, P.10
Malancona, S.11
Hernando, J.I.12
Monteagudo, E.13
Orsale, M.V.14
Palumbi, M.C.15
Pucci, V.16
Rowley, M.17
Sasso, R.18
Scarpelli, R.19
Steinkuhler, C.20
Jones, P.21
more..
-
26
-
-
0031928090
-
Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain
-
DOI 10.1097/00004714-199808000-00012
-
Andree, B.; Nyberg, S.; Ito, H.; Ginovart, N.; Brunner, F.; Jaquet, F.; Halldin, C.; Farde, L. Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain J. Clin. Psychopharmacol. 1998, 18, 317-23 (Pubitemid 28353875)
-
(1998)
Journal of Clinical Psychopharmacology
, vol.18
, Issue.4
, pp. 317-323
-
-
Andree, B.1
Nyberg, S.2
Ito, H.3
Ginovart, N.4
Brunner, F.5
Jaquet, F.6
Halldin, C.7
Farde, L.8
-
27
-
-
33646714901
-
3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys
-
DOI 10.1016/j.pbb.2006.03.007, PII S0091305706000669
-
3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys Pharmacol., Biochem. Behav. 2006, 83, 456-64 (Pubitemid 43736965)
-
(2006)
Pharmacology Biochemistry and Behavior
, vol.83
, Issue.3
, pp. 456-464
-
-
Claytor, R.1
Lile, J.A.2
Nader, M.A.3
-
28
-
-
0021844076
-
3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain
-
DOI 10.1016/0006-2952(85)90778-6
-
2 receptors in the rat brain Biochem. Pharmacol. 1985, 34, 2251-9 (Pubitemid 15061201)
-
(1985)
Biochemical Pharmacology
, vol.34
, Issue.13
, pp. 2251-2259
-
-
Kohler, C.1
Hall, H.2
Ogren, S.-O.3
Gawell, L.4
-
30
-
-
34147207553
-
Galactosidase complementation: A cell-based luminescent assay platform for drug discovery
-
DOI 10.1089/adt.2006.052
-
Olson, K. R.; Eglen, R. M. Beta-galactosidase complementation: a cell-based luminescent assay platform for drug discovery Assay Drug Dev. Technol. 2007, 5, 137-44 (Pubitemid 46581247)
-
(2007)
Assay and Drug Development Technologies
, vol.5
, Issue.1
, pp. 137-144
-
-
Olson, K.R.1
Eglen, R.M.2
-
32
-
-
37049078853
-
Stereoselectivity and Generality of the Palladium-Catalyzed Cyclopropanation of Alpha,Beta-Unsaturated Carboxylic Acids Derivatized with Oppolzers Sultam
-
Vallgarda, J.; Appelberg, U.; Csoregh, I.; Hacksell, U. Stereoselectivity and Generality of the Palladium-Catalyzed Cyclopropanation of Alpha,Beta-Unsaturated Carboxylic Acids Derivatized with Oppolzers Sultam J. Chem. Soc., Perkin Trans. 1 1994, 461-70
-
(1994)
J. Chem. Soc., Perkin Trans. 1
, pp. 461-470
-
-
Vallgarda, J.1
Appelberg, U.2
Csoregh, I.3
Hacksell, U.4
-
33
-
-
14644429214
-
Characterization of Dopamine Receptors
-
In; John Wiley & Sons, Inc. New York.
-
Levant, B. Characterization of Dopamine Receptors. In Current Protocols in Pharmacology; John Wiley & Sons, Inc.: New York, 2001.
-
(2001)
Current Protocols in Pharmacology
-
-
Levant, B.1
|